Flexus Biosciences Secures $38,000,000 Series B Financing

  • Feed Type
  • Date
    12/19/2014
  • Company Name
    Flexus Biosciences
  • Mailing Address
    75 Shoreway Road San Carlos, CA 94070 USA
  • Company Description
    Founded with the mission to create new cancer therapeutics through an innovative application of unexploited insights in immunology.
  • Website
    http://www.flexusbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $38,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company is now well positioned to advance its pipeline of immunotherapies and to select a clinical candidate from its IDO-1 inhibitor program in early 2015.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy